COST-EFFECTIVENESS OF CEFTOLOZANE/TAZOBACTAM AS EMPIRIC THERAPY FOR THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS IN COLOMBIA

被引：0

作者：

Lasalvia, P. ^{[1
]}

Rosselli, D. ^{[2
]}

Castaneda-Cardona, C. ^{[1
]}

Garzon, J. ^{[3
]}

Hernandez, F. ^{[1
]}

Beltran, C. ^{[4
]}

Rojas, M. ^{[4
]}

Lopez, M. C. ^{[5
]}

Sarpong, E. M. ^{[6
]}

机构：

[1] NeuroEconomix, Bogota, Colombia

[2] Pontificia Univ Javeriana, Bogota, Colombia

[3] Hosp San Ignacio, Bogota, Colombia

[4] Merck Sharp & Dohme Ltd, Bogota, Colombia

[5] Merck Sharp & Dhome, Bogota, Colombia

[6] MERCK & CO Inc, Rabway, NJ USA

来源：

VALUE IN HEALTH | 2018年 / 21卷

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PIN35

引用

页码：S152 / S152

页数：1

共 50 条

[21] BUDGET IMPACT ANALYSIS OF CEFTOLOZANE/TAZOBACTAM (ZERBAXA) FORTHE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS AND COMPLICATED URINARY TRACT INFECTIONS IN THE ITALIAN SETTING
Barbieri, M.
Crocchiolo, D.
Veneziano, M. A.
VALUE IN HEALTH, 2016, 19 (07) : A409 - A409
[22] Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections
Kongnakorn, Thitima
Wagenlehner, Florian
Falcone, Marco
Tichy, Eszter
Di Virgilio, Roberto
Baillon-Plot, Nathalie
Charbonneau, Claudie
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (05) : 633 - 641
[23] Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections
Eckmann, Christian
Solomkin, Joseph
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (02) : 271 - 280
[24] In vitro Activity of Ceftolozane/Tazobactam for the Treatment of Complicated Urinary Tract Infections by Escherichia coli in the Era of Antibiotic Resistance "Rejuvenate the mystery"
Farooq, Lubna
Ahmed, Shaikh Nadeem
Khan, Muhammad Aitmaud Uddolah
Ali, Akhtar
Mehmood, Sehrish
Arif, Humaira
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2019, 30 (03)
[25] COST-EFFECTIVENESS EVALUATION OF ERTAPENEM IN THE TREATMENT OF ADULT PATIENTS WITH COMMUNITY-ACQUIRED COMPLICATED URINARY TRACT INFECTIONS
Romero, M.
Barrera, J.
Carrasquilla-Sotomayor, M.
Ruiz, J.
Lopez, M. C.
Rojas, M.
Beltran, C.
VALUE IN HEALTH, 2018, 21 : S153 - S153
[26] The use of ceftolozane-tazobactam in the treatment of complicated intra-abdominal infections and complicated urinary tract infections-A meta-analysis of randomized controlled trials
Cheng, I-Ling
Chen, Yu-Hung
Lai, Chih-Cheng
Tang, Hung-Jen
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (02)
[27] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN COLOMBIA
Diaz-Sotelo, O. D.
Barbosa Castro, T.
Ortiz, Vecino A.
Quevedo, Mould J. F.
Vargas Zea, N.
Prieto Martinez, V
VALUE IN HEALTH, 2013, 16 (03) : A92 - A92
[28] Ceftolozane/tazobactam vs meropenem in neonates and children with complicated urinary tract infection
Dhull, Rachita Singh
INDIAN PEDIATRICS, 2023, 60 (04) : 326 - 326
[29] BUDGET IMPACT ANALYSIS OF INTRODUCING CEFTOLOZANE/TAZOBACTAM INJECTION FOR TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS AND COMPLICATED URINARY TRACT INFECTIONS IN THE MINISTRY OF HEALTH MALAYSIA FACILITIES
Idrus, N.
VALUE IN HEALTH, 2022, 25 (01) : S57 - S57
[30] PIPERACILLIN TAZOBACTAM IN COMPLICATED URINARY-TRACT INFECTIONS
NOWE, P
INTENSIVE CARE MEDICINE, 1994, 20 : S39 - S42

← 1 2 3 4 5 →